Pradaxa Settlement Checks 2024. March 1, 2022 by edward younker. German drug maker boehringer ingelheim announced yesterday that it has reached a $650 million “comprehensive settlement” to resolve close to 4,000 pradaxa.
Headquarters is located in the state), allege that pradaxa caused severe internal. German drug maker boehringer ingelheim announced yesterday that it has reached a $650 million “comprehensive settlement” to resolve close to 4,000 pradaxa.
Boehringer Ingelheim Has Reached A Comprehensive Settlement To Resolve The Remaining Claims Pending In The Pradaxa Litigation.
The fda approved pradaxa in 2010, and within six months, patients were reporting serious bleeding events.
In Addition To The Settlement, Boehringer Ingelheim Also Agreed To Conduct Additional Studies To.
The settlement covers all currently pending.
After A Family Lost Someone To Lung Cancer, Our Compassionate Attorneys Took Their Case And Recovered $91 Million In The Fight Against Big Tobacco.
Images References :
The Makers Of Pradaxa Have Agreed To Pay $3 Billion In A Settlement To Settle Lawsuits Filed By People Harmed By The Drug.
In a connecticut supreme court filing, privately owned boehringer (ingelheim am rhein, germany) stated the settlement would resolve the lawsuits, which alleged the anticoagulant drug pradaxa.
Pradaxa, A Blood Thinner Developed By Boehringer Ingelheim Pharmaceuticals, Currently Faces More Than 2,400 Lawsuits In Connecticut State Court.
Pradaxa lawsuit & settlement information.
The Suits, Brought In Connecticut’s Superior Court (Boehringer Ingelheim’s U.s.